Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3′-BCL11B enhancers and coregulation by PU.1 and HMGA1

Cancer Research

Volumn 67, Issue 4, 2007, Pages 1461-1471

  Nagel, Stefan ^a   Scherr, Michaela ^b   Kel, Alexander ^c   Hornischer, Klaus ^c   Crawford, Gregory E ^d   Kaufmann, Maren ^a   Meyer, Corinna ^a   Drexler, Hans G ^a   MacLeod, Roderick A F ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c BIOBASE GMBH   (Germany)

^d DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HOMEODOMAIN PROTEIN; PROTEIN BCL 11B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR TLX 3; TRICHOSTATIN A; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACETYLATION; AMINO ACID SEQUENCE; ARTICLE; CELL NUCLEUS MATRIX; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 5Q; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DOWN REGULATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T CELL LEUKEMIA;

ACETYLATION; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 5; DEOXYRIBONUCLEASE I; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, LEUKEMIC; HISTONES; HMGA PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, T-CELL, ACUTE; MULTIGENE FAMILY; NUCLEAR MATRIX; OLIGONUCLEOTIDES; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 33847793796     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2615     Document Type: Article

References (50)

1. Wakabayashi Y, Watanabe H, Inoue J, et al. Bcl11b is required for differentiation and survival of αβ T lymphocytes. Nat Immunol 2003;4:533-9.
2. Wakabayashi Y, Inoue J, Takahashi Y, et al. Homozygous deletions and point mutations of the Rit1/Bcl11b gene in γ-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun 2003;301:598-603.
3. Przybylski GK, Dik WA, Wanzeck J, et al. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 2005;19:201-8.
4. Bernard OA, Busson-LeConiat M, Ballerini P, et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001;15:1495-504.
5. Satterwhite E, Sonoki T, Willis TG, et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 2001;98:3413-20.
6. MacLeod RAF, Nagel S, Kaufmann M, Janssen JW, Drexler HG. Activation of HOX11L2 by juxtaposition with 3′-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35:q32.2). Genes Chromosomes Cancer 2003;37:84-91.
7. Nagel S, Kaufmann M, Drexler HG, MacLeod RAF. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res 2003;63:5329-34.
8. Przybylski GK, Dik WA, Grabarczyk P, et al. The effect of a novel recombination between the homeobox gene NKX2-5 and the TRD locus in T-cell acute lymphoblastic leukemia on activation of the NKX2-5 gene. Haematologica 2006;91:317-21.
9. + T lymphocytes. Blood 2006;108:2695-702.
10. Su X, Drabkin H, Clappier E, et al. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3. Genes Chromosomes Cancer 2006;45:846-55.
11. Woolfe A, Goodson M, Goode DK, et al. Highly conserved non-coding sequences are associated with vertebrate development. PloS 2004;Biol 3:e7.
12. Carter D, Chakalova L, Osborne CS, Dai YF, Fraser P. Long-range chromatin regulatory interactions in vivo. Nat Genet 2002;32:623-6.
13. Bode J, Schlake T, Rios-Ramirez M, et al. Scaffold/matrix-attached regions: structural properties creating transcriptionally active loci. Int Rev Cytol 1995;162A:389-454.
14. Bode J, Goetze S, Heng H, Krawetz SA, Benham C. From DNA structure to gene expression: mediators of nuclear compartmentalization and dynamics. Chromosome Res 2003;11:435-45.
15. Vassetzky Y, Hair A, Mechali M. Rearrangement of chromatin domains during development in Xenopus. Genes Dev 2000;14:1541-52.
16. Taunton J, Hassig CA, Schreiber SL. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 1996;272:408-11.
17. Crawford GE, Holt IE, Mullikin JC, et al. Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. Proc Natl Acad Sci U S A 2004;101:992-7.
18. Roh TY, Cuddapah S, Zhao K. Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev 2005;19:542-52.
19. Cutrona G, Carpaneto EM, Ulivi M, et al. Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat Biotechnol 2000;18:300-3.
20. Cutrona G, Carpaneto EM, Ponzanelli A, et al. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the Eμ enhancer. Cancer Res 2003;63:6144-8.
21. Matys V, Kel-Margoulis O, Fricke E, et al. TRANS-FAC(r) and its module TRANSCompel(r): transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006;34:D108-10.
22. Drexler HG. The leukemia-lymphoma cell line facts book. San Diego: Academic Press; 2001.
23. Nagel S, Scherr M, Quentmeier H, et al. HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by P13K signalling involving E2F3. Leukemia 2005;19:841-6.
24. MacLeod RAF, Drexler HG. Cytogenetic characterization of tumor cell lines. Methods Mol Med 2004;88:57-76.
25. Mejia JE, Willmott A, Levy E, Earnshaw WC, Larin Z. Functional complementation of a genetic deficiency with human artificial chromosomes. Am J Hum Genet 2001;69:315-26.
26. Vidakovic M, Koester M, Goetze S, et al. Co-localization of PARP-1 and lamin B in the nuclear architecture: a halo-fluorescence- and confocal-microscopy study. J Cell Biochem 2005;96:555-68.
27. Goetze S, Huesemann Y, Baer A, Bode J. Functional characterization of transgene integration patterns by halo fluorescence in situ hybridization: electroporation versus retroviral infection. Biochemistry 2003;42:7035-43.
28. Eder M, Battmer K, Kafert S, et al. Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation. Leukemia 1999;13:1383-9.
29. Luo Q, Ma X, Wahl SM, Bieker JJ, Crossley M, Montaner LJ. Activation and repression of interleukin-12 p40 transcription by erythroid Kruppel-like factor in macrophages. J Biol Chem 2004;279:18451-6.
30. Scherr M, Battmer K, Ganser A, Eder M. Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA. Cell Cycle 2003;22:251-7.
31. + NOD/SCID-repopulating cells. Blood 2002;99:709-12.
32. Crawford GE, Holt IE, Whittle J, et al. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res 2006;16:123-31.
33. Su XY, Della-Valle V, Andre-Schmutz I, et al. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32). Blood. 2006;108:4189-202.
34. Su XY, Busson M, Della Valle V, et al. Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 2004;41:243-9.
35. Vavouri T, McEwen GK, Woolfe A, Gilks WR, Elgar G. Defining a genomic radius for long-range enhancer action: duplicated conserved non-coding elements hold the key. Trends Genet 2006;22:5-10.
36. de Laat W, Grosveld F. Spatial organization of gene expression: the active chromatin hub. Chromosome Res 2003;11:447-59.
37. Laribee RN, Klemsz MJ. Loss of PU.1 expression following inhibition of histone deacetylases. J Immunol 2001;167:5160-6.
38. Huo X, Zhang J. Important roles of reversible acetylation in the function of hematopoietic transcription factors. J Cell Mol Med 2005;9:103-12.
39. King DC, Taylor J, Elnitski L, et al. Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences. Genome Res 2005;15:1051-60.
40. Lettice LA, Heaney SJ, Purdie LA, et al. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet 2003;12:1725-35.
41. Togashi T, Obata M, Aoyagi Y, Kominami R, Mishima Y. Two distinct methods analyzing chromatin structure using centrirugation and antibodies to modified histone H3: both provide similar chromatin states of the Rit/BcI11b gene. Biochem Biophys Res Commun 2004;313:489-95.
42. Nelsen B, Tian G, Erman B, et al. Regulation of lymphoid-specific immunoglobulin μ heavy chain gene enhancer by ETS-domain proteins. Science 1993;261:82-6.
43. Lewis RT, Andreucci A, Nikolajczyk BS. PU.1-mediated transcription is enhanced by HMG-I(Y)-dependent structural mechanisms. J Biol Chem 2001;276:9550-7.
44. Falvo JV, Thanos D, Maniatis T. Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 1995;83:1101-11.
45. Yie J, Merika M, Munshi N, Chen G, Thanos D. The role of HMG I(Y) in the assembly and function of the IFN-β enhanceosome. EMBO J 1999;18:3074-89.
46. Munshi N, Merika M, Yie J, Senger K, Chen G, Thanos D. Acetylation of HMG I(Y) by CBP turns off IFNβ expression by disrupting the enhanceosome. Mol Cell 1998;2:457-67.
47. McCarthy KM, McDevit D, Andreucci A, Reeves R, Nikolajczyk BS. HMGA1 co-activates transcription in B cells through indirect association with DNA. J Biol Chem 2003;278:42106-14.
48. Bernat JA, Crawford GE, Ogurtsov AY, Collins FS, Ginsburg D, Kondrashov AS. Distant conserved sequences flanking endothelial-specific promoters contain tissue-specific DNase-hypersensitive sites and overrepresented motifs. Hum Mol Genet 2006;15:105.
49. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 2002;419:641-5.
50. Cai S, Han HJ, Kohwi-Shigematsu T. Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 2003;34:42-51.